Specific Activities of Dolastatin 10 and Peptide Derivatives against Cryptococcus neoformans
The biosynthetic peptide dolastatin 10 is currently in phase I and II cancer clinical trials. We evaluated the antifungal spectrum of dolastatin 10 and four structural modifications. In broth macrodilution assays, the peptides were fungicidal for American Type Culture Collection strains and clinical...
Kaydedildi:
| Yayımlandı: | Antimicrob Agents Chemother |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society for Microbiology (ASM)
1998
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC105973/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9797233/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.11.2961 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|